Yuan-Yuan Yang

Yuan-Yuan Yang

Auto-generated profile, based on publicly available information

Yuan-Yuan Yang

State Key Laboratory of Pollution Control and Resource Reuse, College of Environmental Science & Engineering, Tongji University, 1239 Siping Road, Shanghai 200092, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Chemical Engineering Journal
Verified
Journal Article
Closed access
YYYuan-Yuan Yang
Yuan-Yuan Yang
YLYuanting Li
Yuanting Li
XLXue-Jian Li
Xue-Jian Li
LZLei Zhang
Lei Zhang
EFEssy Kouadio Fodjo
Essy Kouadio Fodjo
SHSheng Han
Sheng Han

28 June 2023 in Journal of Hazardous Materials
Verified
Journal Article
Closed access
YYYuanyuan Yang
Yuanyuan Yang
XLXiaohui Liu
Xiaohui Liu
SMShuang Meng
Shuang Meng
SMShun Mao
Shun Mao
WTWenquan Tao
Wenquan Tao
ZLZhuo Li
Zhuo Li

7 March 2020 in Microchimica Acta
Verified
Journal Article
Closed access
PDF file
YLYuanting Li
Yuanting Li
YYYuan-Yuan Yang
Yuan-Yuan Yang
YSYing-Xin Sun
Ying-Xin Sun
YCYue Cao
Yue Cao
YHYan-Shan Huang
Yan-Shan Huang
Sheng HanSheng Han
Sheng Han

1 June 2023 in Human Reproduction
Verified
Journal Article
Open access
PDF file
LQL Qin
L Qin
CCChen Chen
Chen Chen
JWJ Wu
J Wu
LPL C Poon
L C Poon
CWC Wang
C Wang
YWYanfang Wang
Yanfang Wang
The perturbations in serum levels of soluble forms of programmed cell death-1 (sPD-1) and its ligand (sPD-L1) in missed miscarriage (MM) are unknown. Dysfunction in PD-L1 signal has been demonstrated in MM as evidenced by a lower circulating sPD-L1 level and declined expressions of PD-L1 in placenta. Programmed cell death-1 (PD-1) and its ligand (PD-L1) comprise important immune inhibitory checkpoint signaling to maintain pregnancy. During pregnancy, PD-L1 is highly expressed in the trophoblasts of the placenta. The reduced placental PD-L1 expression is associated with the risk of miscarriage. Therefore, disturbance of PD-1/PD-L1 axis in the fetomaternal interface is susceptible to be an important pathogenesis for pregnancy loss. Interestingly, the soluble form of these immune checkpoint molecules is detectable and associated with immunosuppression, it raises the diagnostic potential to monitor their level to monitor pregnancy health. In the discovery cohort, we enrolled 108 patients with MM and 115 body mass index (BMI)-matched, healthy women with a full-term pregnancy at 6 to 13 weeks of gestation. Another cohort of 25 MM patients and 25 subjects with induced abortion was recruited for validation. Blood samples were collected at the first prenatal visit for HP women or on the day of dilatation and curettage surgery (D&C) for subjects with MM or IA to measure serum sPD-1 and sPD-L1 levels. Placenta samples were harvested during the D&C within cohort 2 to examine related gene and protein expression. Our results showed that circulating sPD-L1 levels were reduced by 50% in patients with MM (55.71 ± 1.54 pg/mL) compared to HP controls (107.27 ± 5.48 pg/mL, P<0.001) and remained significant after adjusting for maternal age and gestational age, whereas no significant differences in sPD-1 were observed between the two groups. Applying serum sPD-L1 levels achieved an area under the receiver operating characteristics curve (AUROC) of 0.83 (95% CI: 0.77 to 0.88, P<0.001) with the optimal cut-off value of 81.52 pg/ml to detect MM. Our data in the validation cohort further demonstrated that sPD-L1 was lower in MM patients relative to IA subjects. Likewise, placental PD-L1-related gene expressions were downregulated at both mRNA and protein levels in miscarriage samples relative to samples in IA groups and were positively associated with sPD-L1 levels in maternal circulation This study was conducted in East Asian women, further studies are required for the evaluation of the serum PD-1 and sPD-L1 levels in different ethnic groups. Secondly, due to the cross-sectional nature of the study design, whether the sPD-L1 levels could utilize as a predictive biomarker is questioned. The maternal serum sPD-L1 level has the potential to be a diagnostic aid for pregnancy maintenance. Moreover, insufficient PD-L1 expression in the feto-maternal interface may act as one of the potential pathogenic events to trigger early pregnancy loss. not applicable